Dialysis is a key factor modulating interactions between critical process parameters during the microfluidic preparation of lipid nanoparticles

dc.contributor.authorVargas, Ronny
dc.contributor.authorRomero, Miquel
dc.contributor.authorBerasategui, Tomás
dc.contributor.authorNarváez Narváez, David A.
dc.contributor.authorRamirez, Patricia
dc.contributor.authorNardi Ricart, Anna
dc.contributor.authorGarcía Montoya, Encarna
dc.contributor.authorPérez Lozano, Pilar
dc.contributor.authorSuñé i Negre, Josep M. (Josep Maria)
dc.contributor.authorMoreno Castro, Cristina
dc.contributor.authorHernández Munain, Cristina
dc.contributor.authorSuñe, Carlos
dc.contributor.authorSuñé Pou, Marc
dc.date.accessioned2023-07-19T11:21:35Z
dc.date.available2023-07-19T11:21:35Z
dc.date.issued2023-05-01
dc.date.updated2023-06-21T10:50:30Z
dc.description.abstractManufacturing lipid nanoparticles through microfluidic mixing can be approached from a Quality by Design perspective. Research involving critical process parameters seems to focus on the total flow and flow rate ratio, thus other process variables, such as dialysis, are underestimated. This study used a Design of Experiments to identify the influence of critical process parameters on particle size, polydispersity index, and zeta potential. A response surface Design of Experiments modeled the influence of: total flow (400 to 4000 mu L min-1); flow rate ratio (3 to 9) and dialysis (yes/no). Results suggest that dialysis is a crucial parameter that strongly influences particle size and zeta potential and moderately affects polydispersity index. The flow rate ratio's relevance decreases when dialysis is performed. As the purification method can change the influence of other process parameters, it should be an integrated part of the microfluidic manufacturing of lipid nanoparticles instead of an extra step.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2215-0382
dc.identifier.urihttps://hdl.handle.net/2445/200887
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.colcom.2023.100709
dc.relation.ispartofColloid and Interface Science Communications, 2023, vol. 54, p. 100709
dc.relation.urihttps://doi.org/10.1016/j.colcom.2023.100709
dc.rightscc by-nc-nd (c) Vargas, Ronny et al., 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
dc.subject.classificationDisseny d'experiments
dc.subject.classificationNanopartícules
dc.subject.classificationTecnologia farmacèutica
dc.subject.otherExperimental design
dc.subject.otherNanoparticles
dc.subject.otherPharmaceutical technology
dc.titleDialysis is a key factor modulating interactions between critical process parameters during the microfluidic preparation of lipid nanoparticles
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
1-s2.0-S221503822300016X-main.pdf
Mida:
4.12 MB
Format:
Adobe Portable Document Format